The Globe and Mail spoke with eight people whose pet’s health declined after taking Librela. Drugmaker Zoetis has responded ...
A review of study data by an independent Data Review Committee found that CHAPERONE is not meeting its primary three-year efficacy endpoint Company to discontinue study, review full data set, and eval ...
Blueprint Medicines' AYVAKIT leads its revenue growth, while its pipeline targets multiple cancers. Read why BPMC stock is a ...
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.
Generally, he added, the best value you’ll find are creams, and he’s a fan of Dollar Tree’s CareAll brand arthritis and ...
Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke ...
Proton pump inhibitors are a class of medications used to treat conditions like GERD and ulcers. They work by blocking the ...
Do you have a favorite musical? How many show-tune lyrics do you know? Do you love Broadway? By Shannon Doyne How do you feel about automated vehicles? What effects do you think they will have ...